| Sckc Primary Care | |
|
510 W Radio Ln Arkansas City KS 67005-4011 | |
| (620) 442-6041 | |
| (620) 442-2100 |
| Full Name | Sckc Primary Care |
|---|---|
| Speciality | Clinic/Center |
| Location | 510 W Radio Ln, Arkansas City, Kansas |
| Authorized Official Name and Position | Shanon Ashley (CREDENTIALING SPECIALIST) |
| Authorized Official Contact | 3165001303 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sckc Primary Care 510 W Radio Ln Arkansas City KS 67005-4011 Ph: (620) 442-6041 | Sckc Primary Care 510 W Radio Ln Arkansas City KS 67005-4011 Ph: (620) 442-6041 |
| NPI Number | 1659915734 |
|---|---|
| Provider Enumeration Date | 11/01/2019 |
| Last Update Date | 01/04/2024 |
| Medicare PECOS PAC ID | 1456245802 |
|---|---|
| Medicare Enrollment ID | O20201119001588 |
News Archive
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
Giuseppe Verlato, an epidemiologist at the University of Verona, asked participants to recall whether they smoked between the ages of 11 and 20 and if they had suffered from asthma as young children.
High coronary artery calcium (CAC) together with slow walking speed multiplies the risk of mortality, reveals a new study published in the International Journal of Cardiology. Coronary artery disease is the leading cause of death worldwide and also a common cause of sudden death - heart attack often being the first sign of the disease.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
IntrinsiQ, the company improving the quality and understanding of cancer care, today announced the findings of the company's first IntelliView 360 research study. The biggest outcome: Oncologists believe they treat lung cancer patients in the maintenance setting three times more often than they actually do.
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659915734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
Patients who take prescription opioids for more than 60 days before total knee or hip replacement surgery are at significantly higher risk of being readmitted to the hospital and of undergoing repeat joint-replacement surgery, compared to patients with no preoperative opioid use, reports a study in the July 18 issue of The Journal of Bone & Joint Surgery.
Giuseppe Verlato, an epidemiologist at the University of Verona, asked participants to recall whether they smoked between the ages of 11 and 20 and if they had suffered from asthma as young children.
High coronary artery calcium (CAC) together with slow walking speed multiplies the risk of mortality, reveals a new study published in the International Journal of Cardiology. Coronary artery disease is the leading cause of death worldwide and also a common cause of sudden death - heart attack often being the first sign of the disease.
InnaVirVax, a biopharmaceutical company specialized in the research and development of therapeutic and diagnostic innovations focused on immune dysregulation, announced today that a new European patent application has been filed on VAC-3S, a "first-in-class" immunotherapy for the treatment of HIV infections.
IntrinsiQ, the company improving the quality and understanding of cancer care, today announced the findings of the company's first IntelliView 360 research study. The biggest outcome: Oncologists believe they treat lung cancer patients in the maintenance setting three times more often than they actually do.
› Verified 5 days ago
Kamran Shahzada, M.d. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 515 N Summit St, Arkansas City, KS 67005 Phone: 620-442-4850 Fax: 620-442-9560 | |
Ark City Clinic P A Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 510 W Radio Ln, Arkansas City, KS 67005 Phone: 620-442-2100 Fax: 620-442-8945 | |
Tammy Cullum, Fnp-bc, Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2508 Edgemont Dr Ste 2, Arkansas City, KS 67005 Phone: 620-741-5045 | |
Sckc Speciality Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6403 Patterson Pkwy, Arkansas City, KS 67005 Phone: 620-447-5711 Fax: 620-441-5891 | |
Ark City Clinic P A Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 510 W Radio Ln, Arkansas City, KS 67005 Phone: 620-442-2100 Fax: 620-442-8426 | |
South Central Kansas Clinic Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 515 N Summit St, Arkansas City, KS 67005 Phone: 620-442-4850 Fax: 620-441-5953 |